1. Can antibodies be “vegan”? A guide through the maze of today’s antibody generation methods
   Stefan Dübel, 2024, mAbs CrossRef
2. Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet?
   Markus Friedrich Neurath et al, 2024, Gut CrossRef
3. Specific antitumor activity of anti-CA125 CAR-T lymphocytes against CA125-positive and CA125-negative cells
   T. M. Kulinich et al, 2024, jour CrossRef
4. A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications
   Gertrud Wiedemann et al, 2024, IJMS CrossRef
5. null
   Bhanuprakash Ananthakumar et al, 2024 CrossRef
6. The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap
   Anneliene H. Jonker et al, 2024, Nat Rev Drug Discov CrossRef